Method and apparatus to control delivery of high-voltage and anti-tachy pacing therapy in an implantable medical device

• US 8,170,663 B2
• Filed: 03/16/2007
• Issued: 05/01/2012
• Est. Priority Date: 07/30/2001
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: DeGroot, Paul J., Ousdigian, Kevin T., Padmanabhan, Vasant, Krause, Paul, Sharma, Vinod
• Primary Examiner(s): Layno, Carl H
• Assistant Examiner(s): Patel, Natasha
• Application Number:
  US11/687,282
• Publication Number:
  US 20070156189A1
• Time in Patent Office: 1,873 Days
• Field of Search: 607/4, 607/6, 607/16, 607/34, 607/5, 607/14, 607/12, 607/9
• US Class Current: 607/4
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/3688 configured for switching the pacing mode, e.g. from AAI to DDD
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/39622 Pacing therapy
• CPC Class Codes: A61N 1/3987 characterised by the timing or triggering of the shock

Abstract

A system and method for delivering both anti-tachy pacing (ATP) therapy and high-voltage shock therapy in response to detection of abnormal cardiac rhythms is disclosed. The system controls the time between delivering ATP therapy and the charging of high-voltage capacitors in preparation for shock delivery based on a predetermined set of criteria. In one embodiment, the inventive system operates in an ATP During Capacitor Charging (ATP-DCC) mode wherein all, or substantially all, of the ATP therapy is delivered during charging of the high-voltage capacitors. Based on evaluation of the predetermined set of criteria, the system may switch to an additional ATP Before Capacitor Charging (ATP-BCC) mode, wherein substantially all of the ATP therapy is delivered prior to charging of the high-voltage capacitor. According to one aspect of the invention, the predetermined set of criteria is based, at least in part, on the effectiveness of previously-delivered ATP therapy.

Claims

1. A system for use in controlling electrical therapy delivered to a heart, comprising:

a first circuit that is charged to deliver high-voltage electrical stimulation to the heart;

a second circuit to deliver anti-tachy pacing (ATP) therapy to the heart; and

a control circuit coupled to the first and second circuits to adjust a time of initiation of charging of the first circuit relative to a time of delivering ATP therapy by the second circuit for one delivery of ATP therapy relative to another delivery of ATP therapy.

2. The system of claim 1, wherein the control circuit is configured to operate in a first mode to charge the first circuit to deliver high-voltage electrical stimulation to the heart substantially simultaneously with delivery of ATP therapy to the heart by the second circuit, and a second mode to charge the first circuit to deliver high-voltage electrical stimulation to the heart substantially after delivery of ATP therapy to the heart by the second circuit.

3. The system of claim 2, wherein the control circuit is configured to transition between operating in the first mode and the second mode.

4. The system of claim 3, wherein the control circuit is configured to transition between operating in the first mode and the second mode based on at least one predetermined criteria.

5. The system of claim 4, and further including a storage device coupled to the control circuit to store the at least one predetermined criteria, and wherein the at least one predetermined criteria is programmable.

6. The system of claim 4, and further including at least one electrode coupled to the control circuit to sense cardiac rhythms, and a processing circuit coupled to the control circuit to analyze types of the cardiac rhythms, and wherein the at least one predetermined criteria takes into account the types of the cardiac rhythms occurring in the heart.

7. The system of claim 6, wherein the control circuit includes means for utilizing different values for the at least one predetermined criteria, and wherein the values are respectively associated with a type of cardiac rhythm occurring during delivery of ATP therapy.

8. The system of claim 4, wherein the at least one predetermined criteria includes criteria associated with a change in a type of cardiac rhythm occurring prior to the delivery of ATP therapy.

9. The system of claim 8, wherein the control circuit includes means for transitioning from the first mode to the second mode based on the criteria associated with a change in a type of cardiac rhythm occurring during the delivery of ATP therapy.

10. The system of claim 3, wherein the control circuit is configured to transition between operating in the first mode and the second mode based on the effectiveness of a previously delivery of ATP therapy by the second circuit.

11. The system of claim 3, wherein the control circuit is configured to transition from operating in the first mode and to operating in the second mode based on detection of a predetermined number of successful ATP therapy sessions, wherein a successful ATP therapy session terminates a predetermined abnormal cardiac rhythm.

12. The system of claim 3, wherein the control circuit is configured to transition between from operating in the second mode to operating in the first mode based on detection of a predetermined number of unsuccessful ATP therapy sessions, wherein an unsuccessful ATP therapy session fails to terminate a predetermined abnormal cardiac rhythm.

13. The system of claim 3, wherein the control circuit is configured to transition between operating in the first mode and the second mode based on a frequency of occurrence of a predetermined cardiac rhythm.

14. The system of claim 3, wherein the control circuit is configured to transition between the first mode and the second mode based on detection of a predetermined number of VT episodes.

15. The system of claim 3, wherein the control circuit is configured to transition between the first mode and the second mode based on detection of a predetermined number of VT episodes detected in a predetermined period of time.

16. The system of claim 3, wherein the control circuit is configured to transition between the first mode and the second mode based on a duration of a VT episode.

17. The system of claim 16, wherein the control circuit is configured to transition between the first mode and the second mode based on comparison of a duration of a VT episode to a predetermined value to determine whether a previously delivered ATP therapy was successful.

18. The system of claim 3, wherein the control circuit is configured to transition between operating in the first mode and the second mode in response to a length of an episode corresponding to a previously delivered ATP therapy.

19. A method for use in delivering electrical stimulation to a heart, comprising:

delivering anti-tachy pacing (ATP) therapy to a patient'"'"'s heart;

charging a high-voltage capacitor in preparation to deliver high voltage electrical stimulation to the heart; and

adjusting a time of initiation of charging the high-voltage capacitor in preparation to deliver high-voltage electrical stimulation to the heart in relation to a time of delivering the ATP therapy to the patient'"'"'s heart for one delivery of ATP therapy relative to another delivery of ATP therapy.

20. The method of claim 19, wherein adjusting a time of charging the high-voltage capacitor in preparation to deliver high-voltage electrical stimulation to the heart in relation to a time of delivering the ATP therapy to the patient'"'"'s heart comprises:

operating in a first mode to charge the first circuit to deliver high-voltage electrical stimulation to the heart substantially simultaneously with delivery of ATP therapy to the heart by the second circuit; and

operating in a second mode to charge the first circuit to deliver high-voltage electrical stimulation to the heart substantially after delivery of ATP therapy to the heart by the second circuit.

21. The method of claim 20, further comprising:

transitioning between operating in the first mode and the second mode.

22. The method of claim 21, wherein transitioning between operating in the first mode and the second mode includes transitioning based on at least one predetermined criteria.

23. The method of claim 21, wherein transitioning between operating in the first mode and the second mode includes transitioning based on detection of at least one cardiac depolarization.

24. The method of claim 21, wherein transitioning between operating in the first mode and the second mode includes transitioning based on detecting a frequency of occurrence of a predetermined cardiac rhythm.

25. The method of claim 21, wherein transitioning between operating in the first mode and the second mode includes transitioning based on detecting a ventricular tachycardia (VT).